Maria Caridad Young
Family · Reston, VANPI 1447840665
Payments from drug & device makers
Across 75 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$219
- Otsuka America Pharmaceutical, Inc.$181
- AstraZeneca$170
- Lilly USA, LLC$159
- Pfizer$108
- GSK$100
- plus $542 from 21 others
What the payments were for
- Food & beverage$1,479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $219 |
| Otsuka America Pharmaceutical, Inc. | 4 | $181 |
| AstraZeneca | 9 | $170 |
| Lilly USA, LLC | 9 | $159 |
| Pfizer | 6 | $108 |
| GSK | 5 | $100 |
| Astellas Pharma US Inc | 3 | $71 |
| Coala Life Inc | 1 | $68 |
| IBSA Pharma Inc. | 4 | $55 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Medtronic | 2 | $30 |
| Cranial Technologies, Inc | 2 | $30 |
| QOL Medical, LLC | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| AbbVie | 1 | $21 |
| Exact Sciences | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Qorumpartners | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Gilead | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Merck | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$125
How this compares
$1,479 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trospium Chloride | 11 | $1,029 |
| Atorvastatin Calcium | 43 | $444 |
| Levothyroxine Sodium | 36 | $307 |
| Rosuvastatin Calcium | 37 | $260 |
| Pantoprazole Sodium | 19 | $251 |
| Losartan Potassium | 37 | $170 |
| Lisinopril | 23 | $147 |
| Gabapentin | 23 | $145 |
| Metformin Hcl | 30 | $140 |
| Amlodipine Besylate | 20 | $107 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $69 |
| Hydrochlorothiazide | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other family in Reston
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.